Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

148 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Eligibility Advanced Adult Hepatocellular Carcinoma NCT02418988

- 27/09/21 - 1 modulo, 2 itemgroups, 19 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02418988

Eligibility Advanced Adult Hepatocellular Carcinoma NCT01405573

- 10/04/21 - 1 modulo, 2 itemgroups, 17 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01405573

Eligibility Hepatocellular Carcinoma NCT02149771

- 20/09/21 - 1 modulo, 2 itemgroups, 9 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Combination Treatment for Advanced Liver Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02149771

Eligibility Advanced Hepatocellular Carcinoma NCT02150317

- 29/05/16 - 1 modulo, 2 itemgroups, 12 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02150317

Eligibility Advanced Adult Hepatocellular Carcinoma NCT02409524

- 27/05/16 - 1 modulo, 2 itemgroups, 32 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT02409524

Eligibility NCT01246986 Carcinoma - Eligibility

- 27/09/21 - 1 modulo, 2 itemgroups, 27 elementi, 2 lingue
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01246986

Eligibility Carcinoma, Hepatocellular NCT00901901

- 20/09/21 - 1 modulo, 2 itemgroups, 16 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00901901

Eligibility Hepatocellular Carcinoma NCT00518557

- 20/09/21 - 1 modulo, 2 itemgroups, 21 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis; ODM derived from: https://clinicaltrials.gov/show/NCT00518557

Eligibility Carcinoma, Hepatocellular NCT00056992

- 20/09/21 - 1 modulo, 1 ItemGroup, 20 elementi, 1 linguaggio
ItemGroup: Criteria
Testing of ADI-PEG in Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00056992

Eligibility Hepatocellular Carcinoma NCT00149565

- 20/09/21 - 1 modulo, 1 ItemGroup, 25 elementi, 1 linguaggio
ItemGroup: Inclusion Criteria
Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00149565

Eligibility NCT00855218 Carcinoma, Hepatocellular - Eligibility

- 17/09/21 - 1 modulo, 2 itemgroups, 16 elementi, 2 lingue
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00855218

Eligibility Hepatocellular Carcinoma NCT00155272

- 17/09/21 - 1 modulo, 2 itemgroups, 23 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00155272

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial